NLRP3 and atherosclerosis: ZTLT has been shown to limit foam cell formation and reduce lipid levels by preventing vascular inflammation and macrophage pyroptosis through the Piezo1/NLRP3 signaling pathway, thus slowing the progression of atherosclerosis (121).